Encompass Health Corp (NYSE:EHC) has been assigned an average recommendation of “Buy” from the seven analysts that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $80.75.
Separately, ValuEngine upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Monday, February 4th.
Shares of EHC stock traded down $1.20 during mid-day trading on Friday, hitting $60.96. 104,464 shares of the company’s stock were exchanged, compared to its average volume of 854,322. Encompass Health has a fifty-two week low of $56.74 and a fifty-two week high of $82.46. The company has a quick ratio of 0.89, a current ratio of 0.89 and a debt-to-equity ratio of 1.71. The stock has a market capitalization of $6.37 billion, a price-to-earnings ratio of 16.79, a price-to-earnings-growth ratio of 2.16 and a beta of 0.74.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 1.77%. The ex-dividend date of this dividend is Friday, June 28th. Encompass Health’s dividend payout ratio (DPR) is 29.75%.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.